Medicine for treating hyperplasia of mammary glands

Abstract

The invention discloses a medicine for treating hyperplasia of mammary glands, and the medicine comprises the following components by weight: 10-20 parts of Green Tangerine Peel, 10-20 parts of Serissa japonica, 15-25 parts of Prunella, 15-25 parts of radix curcumae, 10-20 parts of cowherb seed, 12-20 parts of safflower, 15-25 parts of salviae miltiorrhizae, 10-18 parts of Chinese angelica, 10-16 parts of Radix Paeoniae Rubra, 8-16 parts of Bupleurum, 5-15 parts of finger citron, 15-25 parts of anise and 15-25 parts of fennel. Through years of clinical observation, 100 patients with hyperplasia of mammary glands are selected, 3 months after application of the medicine, 52 patients are cured by statistics, the cured patients account for 52%; the medicine takes effect on 45 patients accounting for 45%; the medicine takes no effect on 3 patients; by testing and verification, about 2 weeks after application of the medicine, the effect is significant, 2 months after application of the medicine, symptoms are disappeared or reduced; the total efficiency is 97%, and the hyperplasia of mammary glands is not easy to relapse.

Description

technical field [0001] The invention relates to a medicine for treating mammary gland hyperplasia, which belongs to the technical field of medicines. Background technique [0002] Breast hyperplasia is the most common breast disease in women, and its incidence rate accounts for the first place in breast diseases. In recent years, the incidence of the disease has been increasing year by year, and the age is getting younger and younger. In adolescent or young women, there is breast distending pain before menstruation, and sometimes the pain spreads to the shoulder and back. After menstruation, the breast pain gradually relieves itself, and only some thickening of the breast can be felt without obvious nodules. These are physiological changes, not The disease does not require treatment, and it is a physiological hyperplasia. Mammary gland hyperplasia is the physiological hyperplasia and incomplete involution of normal mammary gland lobules, and the normal structure of the mam...

AI Technical Summary

Problems solved by technology

Western medicine treatment of mammary gland hyperplasia is to regulate ovarian endocrine or block hormone targets, block the pathogenesis, and relieve symptoms. Therefore, estrogen-suppressing drugs are often used in the treatment plan. The amount and application time of hormones are difficult to properly meet the needs of the disease, and there is often the disadvantage of overcorrecting; improper application will inevitably aggravate the already imbalanced state